Genzyme Receives Positive CHMP Opinion for LEMTRADA (alemtuzumab) in ... PipelineReview.com (press release) CAMBRIDGE, MA, USA I June 28, 2013 I Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive ... |
